{"id":230553,"date":"2020-09-07T09:35:00","date_gmt":"2020-09-07T08:35:00","guid":{"rendered":"https:\/\/eu.intelligentlabs.org\/inozitols-prieks-pos-uztura-bagatinatajs-kas-patiesam-darbojas\/"},"modified":"2020-09-07T09:35:00","modified_gmt":"2020-09-07T08:35:00","slug":"inozitols-prieks-pos-uztura-bagatinatajs-kas-patiesam-darbojas","status":"publish","type":"post","link":"https:\/\/eu.intelligentlabs.org\/lv-lv\/inozitols-prieks-pos-uztura-bagatinatajs-kas-patiesam-darbojas\/","title":{"rendered":"Inozitols Priek\u0161 POS: Uztura Bag\u0101tin\u0101t\u0101js, kas patie\u0161\u0101m darbojas?"},"content":{"rendered":"\n

Policistisko oln\u012bncu sindroms (POS) aizskar visda\u017e\u0101d\u0101k\u0101s sievietes. Varb\u016bt ar\u012b tas neapdraud dz\u012bv\u012bbu,bet, ja tas netiek \u0101rst\u0113ts, tas var progres\u0113t l\u012bdz daudz nopietn\u0101k\u0101m medic\u012bniskaj\u0101m probl\u0113m\u0101m, k\u0101 otr\u0101 tipa diab\u0113tu un kardiovaskul\u0101raj\u0101m probl\u0113m\u0101m. \u0160aj\u0101 rakst\u0101, j\u016bs vai uzzin\u0101siet uztura bag\u0101tin\u0101\u0161anu ar inzitolu priek\u0161 POS ir efekt\u012bva \u0101rst\u0113\u0161anas iesp\u0113ja. Ja j\u016bs izlas\u012bsiet to l\u012bdz galam, j\u016bs ar\u012b uzzin\u0101siet, kas ir lab\u0101kais inzitola uztura bag\u0101tin\u0101t\u0101js, k\u0101ds ir pieejams vis\u0101 tirg\u016b.<\/p>\n\n\n\n

Kas Tie\u0161i Ir Inzitols?<\/strong><\/h2>\n\n\n\n

Inzitols ir dab\u012bgs cukurs, kas bie\u017ei ir atrodams graudos, aug\u013cos un riekstos. Apels\u012bni un kantalupas ir divi labi piem\u0113ri ar aug\u013ciem ar augstu inzitola saturu. M\u016bsu \u0137ermenis ar\u012b ra\u017eo inzitolu no glukozes, t\u0101d\u0113\u013c \u0161\u012b viela mums nav sve\u0161a. Paties\u012bb\u0101, m\u016bsu nieres ra\u017eo aptuveni divus gramus inzitola dien\u0101.<\/p>\n\n\n\n

Inzitols ir svar\u012bga m\u016bsu \u0161\u016bnu membr\u0101nu sast\u0101vda\u013ca. Tas ietekm\u0113 neirotransmiterus smadzen\u0113s, ieskaitot garst\u0101vok\u013cu hormonus seroton\u012bnu un dopam\u012bnu. Tas ar\u012b pal\u012bdz regul\u0113t asins cukuru, pateicoties efektam, k\u0101du tas atst\u0101j uz insul\u012bnu. <\/p>\n\n\n\n

Past\u0101v 9 izom\u0113riskas inozitola formas, mioinozitolam esot pa\u0161ai izplat\u012bt\u0101kai. Tas var p\u0101rv\u0113rsties cit\u0101s form\u0101s, piem\u0113ram d-chiro-inozitol\u0101, kad \u0137ermenim tas ir nepiecie\u0161ams (1). J\u016bs iem\u0101c\u012bsieties vair\u0101k par to, k\u0101 mioinozitols un d-chiro-inozitols kop\u012bgi str\u0101d\u0101, lai c\u012bn\u012btos ar POS, t\u0101d\u0113\u013c turpiniet las\u012bt!<\/p>\n\n\n\n

L\u016bk, viens interesants fakts: inozitola pulveris gar\u0161o uz pusi tik pat saldi k\u0101 cukurs un tiek bie\u017ei lietots k\u0101 rekvez\u012bts koka\u012bna aizvieto\u0161anai film\u0101s. T\u0101d\u0113\u013c, n\u0101kamo reizi, kad j\u016bs redz\u0113siet j\u016bsu m\u012b\u013c\u0101ko aktieri, \u0161\u0146aucot baltu pulveri no galda, tas, visticam\u0101k, ir inozitols! <\/p>\n\n\n\n

\"sieviete<\/figure>\n\n\n\n

POS un Insul\u012bna Pretest\u012bba<\/strong><\/h2>\n\n\n\n

Tradicion\u0101li, POS \u0101rst\u0113\u0161ana noz\u012bm\u0113ja individu\u0101lu simptomu \u0101rst\u0113\u0161anu, jums sa\u0146emot recepti medikamentiem, lai atjaunotu m\u0113ne\u0161reizes, nov\u0113rstu matu izkri\u0161anu vai pie\u0146em\u0161anos svar\u0101. Tai pat laik\u0101, saknes c\u0113lonis bie\u017ei paliek ne\u0101rst\u0113ts un simptomi turpina atgriezties.<\/p>\n\n\n\n

Lai ar\u012b POS c\u0113lo\u0146i v\u0113l joproj\u0101m nav zin\u0101mi, past\u0101v p\u0101ris teorijas. Atsaucoties uz vienu no t\u0101m, tas ir iedzimta kaite, kuru var saasin\u0101t aptauko\u0161an\u0101s (2). Atsaucoties uz citu, ja meiten\u012btes pirms dzim\u0161anas tiek pak\u013cautas augstiem androg\u0113nu l\u012bme\u0146iem, palielin\u0101s vi\u0146u iesp\u0113ja att\u012bst\u012bt POS v\u0113l\u0101k dz\u012bv\u0113 (3). Visbeidzot, to var\u0113tu izrais\u012bt ar\u012b insul\u012bna pretest\u012bba vai insul\u012bna nej\u016bt\u012bgums (4). \u0160aj\u0101 rakst\u0101, m\u0113s koncentr\u0113simies uz insul\u012bna pretest\u012bbas \u0101rst\u0113\u0161anu, lai mazin\u0101tu POS simptomus.<\/p>\n\n\n\n

Bet k\u0101 insul\u012bns ir saist\u012bts ar POS?<\/strong><\/h3>\n\n\n\n

Insul\u012bns ir hormons, kas p\u0101rv\u0113r\u0161 og\u013chidr\u0101tus no j\u016bsu ap\u0113stajiem \u0113dieniem cukur\u0101 vai glukoz\u0113, lai \u0137ermenis tos var\u0113tu izmantot, k\u0101 ener\u0123ijas avotus. Tas regul\u0113 j\u016bsu asins cukura l\u012bme\u0146us, uzglab\u0101jot lieko glukozi j\u016bsu nier\u0113s, musku\u013cos un tauku \u0161\u016bn\u0101s. V\u0113l\u0101k \u0137ermenis lieto \u0161o uzglab\u0101to glukozi, kad j\u016bsu \u0137erme\u0146a cukura l\u012bme\u0146i ir nokritu\u0161ies, vai ar\u012b p\u0113c nogurdino\u0161\u0101m fizisk\u0101m aktivit\u0101t\u0113m, kas pat\u0113r\u0113 daudz ener\u0123ijas (5). <\/h3>\n\n\n\n

Tom\u0113r, ja j\u016bs \u0113dat p\u0101r\u0101k daudz og\u013chidr\u0101tu, nepat\u0113r\u0113jot l\u012bdz\u012bgu ener\u0123ijas daudzumu (d\u0113\u013c s\u0113do\u0161a dz\u012bvesveida), j\u016bsu asins cukura l\u012bme\u0146i saglab\u0101jas b\u012bstami augstu. J\u016bsu aizku\u0146\u0123a dziedzeris ra\u017eo vai\u0157ak insul\u012bna, lai samazin\u0101t augstos cukura l\u012bme\u0146us. <\/p>\n\n\n\n

Ilgsto\u0161i paaugstin\u0101ts insul\u012bns izraisa insul\u012bna pretest\u012bbu, tas noz\u012bm\u0113, ka insul\u012bns vairs nedarbojas t\u0101, k\u0101 tam vajadz\u0113tu, l\u012bdz ar to asins cukura l\u012bme\u0146i paliek nekontrol\u0113ti. Tas v\u0113l\u0101k var izrais\u012bt nopietnus medic\u012bnisk\u0101s kaites, k\u0101 otr\u0101 tipa diab\u0113tu, aklumu, nieru atteik\u0161anos un sirds slim\u012bbas.<\/p>\n\n\n\n

Insul\u012bna pretest\u012bba izraisa hormonu disbalansu. J\u016bsu estrog\u0113na l\u012bme\u0146i kr\u012btas un j\u016bsu testosterona (v\u012bri\u0161\u0137ais hormons) l\u012bmenis ce\u013cas. \u0160\u012b iemesla d\u0113\u013c daudzi POS simptomi izpau\u017eas k\u0101 tipiski v\u012bri\u0161\u0137as paz\u012bme. Piem\u0113ram, nev\u0113lams apmatojums uz sejas (\u016bsi\u0146as, b\u0101rda), neregul\u0101ras vai p\u0101rtrauktas m\u0113ne\u0161reizes un matu izkri\u0161ana galvas vid\u016b, glu\u017ei k\u0101 tipiskas v\u012brie\u0161u plikpaur\u012bbas gad\u012bjumos (6).<\/p>\n\n\n\n

\"inozitls<\/figure>\n\n\n\n

K\u0101 Inozitols Pal\u012bdz Ar POS<\/strong><\/h2>\n\n\n\n

Turpin\u0101jum\u0101 apskat\u012bsim p\u0101ris veidus, k\u0101 inozitols var pal\u012bdz\u0113t sieviet\u0113m ar POS:<\/p>\n\n\n\n

Mazin\u0101ta insul\u012bna pretest\u012bba:<\/p>\n\n\n\n

Konstantino ar kol\u0113\u0123iem veica divk\u0101r\u0161i aklo p\u0113t\u0113jumi ar 42 sieviet\u0113m, kur\u0101m ir POS. Vi\u0146i \u0101rst\u0113ja pusi no sieviet\u0113m ar mioinozitola un folsk\u0101bi. Otra puse sa\u0146\u0113ma tikai folsk\u0101bi. At\u0161\u0137ir\u012bba starp ab\u0101m grup\u0101m bija satrauco\u0161a. Pirm\u0101 grupa demonstr\u0113ja insul\u012bna j\u016bt\u012bguma pieaugumu, zem\u0101ku asinsspiedienu, zem\u0101kus griglicer\u012bdu l\u012bme\u0146us un zem\u0101kus testosterona l\u012bme\u0146us, sal\u012bdzin\u0101jum\u0101 ar otro grupu (7).<\/p>\n\n\n\n

Uzlabo oln\u012bcu aktivit\u0101ti<\/p>\n\n\n\n

Ovul\u0101cija ir pirmais solis pret\u012b augl\u012bbai un gr\u016btniec\u012bbai. Sieviet\u0113m ar neregul\u0101r\u0101m m\u0113ne\u0161reiz\u0113m, tas ir pirmais simptoms, kas b\u016btu j\u0101\u0101rst\u0113 p\u0113c iesp\u0113jas \u0101tr\u0101k. P\u0113t\u012bjum\u0101, kura tika apskat\u012btasa 50 sievietes ar POS un insul\u012bna pretest\u012bbu, kur\u0101m p\u0113tnieki izrakst\u012bja mioinozitolu. Vi\u0146i atkl\u0101ja, ka tas pal\u012bdz\u0113ja uzlabot insul\u012bna j\u016bt\u012bgumu un ar\u012b \u0137erme\u0146a masas indeksu. Tas ar\u012b pal\u012bdz\u0113ja 29 sieviet\u0113m ovul\u0113t (v\u0113l\u0101k, 11 no 29 veiksm\u012bgi uzs\u0101ka gr\u016btniec\u012bbu) (8).<\/p>\n\n\n\n

Uzlabo aug\u013ca olas kvalit\u0101tiI<\/p>\n\n\n\n

Aug\u013ca olas kvalit\u0101te var b\u016bt at\u0161\u0137ir\u012bba starp vesel\u012bgu un problem\u0101tisku gr\u016btniec\u012bbu. Sievietes ar POS netikai cie\u0161 no neregul\u0101r\u0101m m\u0113ne\u0161reiz\u0113m, bet ar\u012b no v\u0101j\u0101kas kvalit\u0101tes ol\u0101m. Par laimi, bag\u0101tinot uzturu ar mioinozitolu uzlabo POS pacien\u0161u olu kvalit\u0101ti, kas noved pie vesel\u012bgas gr\u016btniec\u012bbas (9).<\/p>\n\n\n\n

Nov\u0113r\u0161 gest\u0101cijas diab\u0113tu<\/p>\n\n\n\n

Gr\u016btnieces, kuras cie\u0161 no insul\u012bna pretest\u012bbas, risk\u0113 att\u012bst\u012bt gest\u0101cijas diab\u0113tu. Tom\u0113r, p\u0113tnieki ir atkl\u0101ju\u0161i, ka bag\u0101tinot uzturu ar mioinozitolu, \u0161is risks iev\u0113rojami mazin\u0101s. Sievietes ar\u012b dzemd\u0113ja maz\u0101kus un vesel\u012bg\u0101kus b\u0113rni\u0146us, v\u0113l\u0101k\u0101 gest\u0101cijas vecum\u0101 (10).<\/p>\n\n\n\n

Uzlabo asinsspiedienu un triglicer\u012bdu l\u012bme\u0146us<\/p>\n\n\n\n

Mioinozitols var\u0113tu b\u016bt \u0137erme\u0146a galvenais inozitols, bet p\u0113t\u012bjums, kas apskat\u012bja d-chiro-inozitolu, demonstr\u0113ja, ka, papildus pal\u012bdz\u0113\u0161anai uzlabot insul\u012bna j\u016bt\u012bgumu POS pacientiem, tas ar\u012b mazina sievie\u0161u plazmas triglicer\u012bdu skaitu koncentr\u0101ciju. Papildus, iev\u0113rojami samazin\u0101j\u0101s ar\u012b pacienta diastoliskais un sistoliskais asinsspiediens (11).<\/p>\n\n\n\n

Pazemina testosterona l\u012bme\u0146us<\/p>\n\n\n\n

Augsti testosterona l\u012bme\u0146i ir atbid\u012bgi par smagu akni, pl\u0101niem matiem un hirsutismu.Ja j\u016bs cie\u0161at no \u0161iem simptomiem, apsveriet inozitola lieto\u0161anu, POS atvieglo\u0161anai. Dubulti akl\u0101 p\u0113t\u012bjum\u0101, p\u0113tnieki demonstr\u0113ja noz\u012bm\u012bgu testosterona l\u012bmens kritumu, \u0101rst\u0113jot sievietes ar mioinozitola un folsk\u0101bi (7).<\/p>\n\n\n\n

\"sieviete<\/figure>\n\n\n\n

Nosl\u0113gum\u0101<\/strong><\/h2>\n\n\n\n

Pat tad, ja ar\u012b POS v\u0113l nav \u0101rst\u0113jams, bet t\u0101 simptomi ir kontrol\u0113jami. Piekopjot vesel\u012bgu dz\u012bvesveidu – ieturot POS draudz\u012bgu di\u0113tu<\/a> un k\u013c\u016bstot fiziski akt\u012bv\u0101k\u0101m, var pal\u012bz\u0113t uzlabot j\u016bsu simptomus. Pal\u012bdz ar\u012b uztura bag\u0101tin\u0101\u0161ana ar inozitolu. Lai j\u016bs var\u0113tu b\u016bt p\u0101rliecin\u0101ta, ka j\u016bsu simptomi neatgriez\u012bsies, jums ir stingri j\u0101pieturas pie \u0161\u012b jaun\u0101 dz\u012bvesveida. Ja j\u016bs esiet izm\u0113\u0123in\u0101ju\u0161i Hromistolu-F (vai jebk\u0101du citu inozitola uztura bag\u0101tin\u0101t\u0101ju), daieties sav\u0101 pieredz\u0113 koment\u0101ros!<\/p>\n\n\n\n

Supplementing with inositol also helps. To ensure your symptoms never make a comeback, it\u2019s important to commit to this new lifestyle. Do let us know in the comments below if you\u2019ve tried out Chromositol-F (or any other inositol supplement) to treat your PCOS symptoms!<\/p>\n\n\n\n

Atsauces:<\/p>\n\n\n\n

(1) Larner, Joseph et al. \u201cD-chiro-inositol glycans in insulin signaling and insulin resistance.\u201d Molecular medicine (Cambridge, Mass.) vol. 16,11-12 (2010): 543-52. doi:10.2119\/molmed.2010.00107<\/p>\n\n\n\n

(2) Legro RS, Strauss JF (2002). \u201cMolecular progress in infertility: polycystic ovary syndrome\u201d. Fertil. Steril. 78 (3): 569\u201376. doi:10.1016\/S0015-0282(02)03275-2<\/p>\n\n\n\n

(3) Panagiota Filippou, Roy Homburg, Is foetal hyperexposure to androgens a cause of PCOS?, Human Reproduction Update, Volume 23, Issue 4, July-August 2017, Pages 421\u2013432, https:\/\/doi.org\/10.1093\/humupd\/dmx013<\/p>\n\n\n\n

(4) Lisa J. Moran, Marie L. Misso, Robert A. Wild, Robert J. Norman, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis, Human Reproduction Update, Volume 16, Issue 4, July-August 2010, Pages 347\u2013363, https:\/\/doi.org\/10.1093\/humupd\/dmq001<\/p>\n\n\n\n

(5) Wilcox, Gisela. \u201cInsulin and insulin resistance.\u201d The Clinical biochemist. Reviews vol. 26,2 (2005): 19-39.<\/p>\n\n\n\n

(6) Rodriguez Paris, Valentina, and Michael J Bertoldo. \u201cThe Mechanism of Androgen Actions in PCOS Etiology.\u201d Medical sciences (Basel, Switzerland) vol. 7,9 89. 28 Aug. 2019, doi:10.3390\/medsci7090089<\/p>\n\n\n\n

(7) Costantino, D et al. \u201cMetabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.\u201d European review for medical and pharmacological sciences vol. 13,2 (2009): 105-10.<\/p>\n\n\n\n

(8) Kamenov, Zdravko et al. \u201cOvulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.\u201d Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. 31,2 (2015): 131-5. doi:10.3109\/09513590.2014.964640<\/p>\n\n\n\n

(9) Zheng, Xiangqin et al. \u201cInositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET.\u201d Medicine vol. 96,49 (2017): e8842. doi:10.1097\/MD.0000000000008842<\/p>\n\n\n\n

(10) Matarrelli, Barbara et al. \u201cEffect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.\u201d The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. 26,10 (2013): 967-72. doi:10.3109\/14767058.2013.766691<\/p>\n\n\n\n

(11) Nestler, J E et al. \u201cOvulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.\u201d The New England journal of medicine vol. 340,17 (1999): 1314-20. doi:10.1056\/NEJM199904293401703<\/p>\n","protected":false},"excerpt":{"rendered":"

Policistisko oln\u012bncu sindroms (POS) aizskar visda\u017e\u0101d\u0101k\u0101s sievietes. Varb\u016bt ar\u012b tas neapdraud dz\u012bv\u012bbu,bet, ja tas netiek \u0101rst\u0113ts, tas var progres\u0113t l\u012bdz daudz nopietn\u0101k\u0101m medic\u012bniskaj\u0101m probl\u0113m\u0101m, k\u0101 otr\u0101 tipa diab\u0113tu un kardiovaskul\u0101raj\u0101m probl\u0113m\u0101m. \u0160aj\u0101 rakst\u0101, j\u016bs vai uzzin\u0101siet uztura bag\u0101tin\u0101\u0161anu ar inzitolu priek\u0161 POS ir efekt\u012bva \u0101rst\u0113\u0161anas iesp\u0113ja. Ja j\u016bs izlas\u012bsiet to l\u012bdz galam, j\u016bs ar\u012b uzzin\u0101siet,…<\/p>\n","protected":false},"author":2,"featured_media":129455,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[2961,2962],"tags":[],"coauthors":[],"class_list":["post-230553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-labklajiba","category-veseliba"],"taxonomy_info":{"category":[{"value":2961,"label":"Labkl\u0101j\u012bba"},{"value":2962,"label":"Vesel\u012bba"}]},"featured_image_src_large":["https:\/\/eu.intelligentlabs.org\/wp-content\/uploads\/2020\/08\/featured-1024x557.jpg",1024,557,true],"author_info":{"display_name":"David Pashley","author_link":"https:\/\/eu.intelligentlabs.org\/lv-lv\/author\/david\/"},"comment_info":0,"category_info":[{"term_id":2961,"name":"Labkl\u0101j\u012bba","slug":"labklajiba","term_group":0,"term_taxonomy_id":2961,"taxonomy":"category","description":"","parent":0,"count":26,"filter":"raw","cat_ID":2961,"category_count":26,"category_description":"","cat_name":"Labkl\u0101j\u012bba","category_nicename":"labklajiba","category_parent":0},{"term_id":2962,"name":"Vesel\u012bba","slug":"veseliba","term_group":0,"term_taxonomy_id":2962,"taxonomy":"category","description":"","parent":0,"count":13,"filter":"raw","cat_ID":2962,"category_count":13,"category_description":"","cat_name":"Vesel\u012bba","category_nicename":"veseliba","category_parent":0}],"tag_info":false,"wpml":{"language":"lv-lv","is_original":false,"original_post_id":131454,"translations":{"bg-bg":{"id":225603,"language":"bg-bg","is_original":false},"cs-cz":{"id":218987,"language":"cs-cz","is_original":false},"da-dk":{"id":222363,"language":"da-dk","is_original":false},"de-at":{"id":170594,"language":"de-at","is_original":false},"de-de":{"id":46553,"language":"de-de","is_original":false},"el-cy":{"id":229502,"language":"el-cy","is_original":false},"el-gr":{"id":228258,"language":"el-gr","is_original":false},"en-gb":{"id":131454,"language":"en-gb","is_original":true},"en-ie":{"id":166604,"language":"en-ie","is_original":false},"en-mt":{"id":166230,"language":"en-mt","is_original":false},"es-es":{"id":47910,"language":"es-es","is_original":false},"fi-fi":{"id":238473,"language":"fi-fi","is_original":false},"fr-fr":{"id":46505,"language":"fr-fr","is_original":false},"hu-hu":{"id":225097,"language":"hu-hu","is_original":false},"it-it":{"id":58734,"language":"it-it","is_original":false},"lt-lt":{"id":230982,"language":"lt-lt","is_original":false},"lv-lv":{"id":230553,"language":"lv-lv","is_original":false},"nl-be":{"id":217816,"language":"nl-be","is_original":false},"nl-nl":{"id":172004,"language":"nl-nl","is_original":false},"pl-pl":{"id":195077,"language":"pl-pl","is_original":false},"pt-pt":{"id":168192,"language":"pt-pt","is_original":false},"ro-ro":{"id":237500,"language":"ro-ro","is_original":false},"sk-sk":{"id":238087,"language":"sk-sk","is_original":false},"sv-se":{"id":223203,"language":"sv-se","is_original":false}}},"_links":{"self":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/comments?post=230553"}],"version-history":[{"count":0,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/posts\/230553\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media\/129455"}],"wp:attachment":[{"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/media?parent=230553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/categories?post=230553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/tags?post=230553"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/eu.intelligentlabs.org\/lv-lv\/wp-json\/wp\/v2\/coauthors?post=230553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}